Genital Herpes Treatment Market is forecast to exceed the valuation of US$ 2881.8 Million by the end of 2031

The global Genital Herpes Treatment Market is predicted to grow rapidly and surpass US$ 2881.8 Million by the end of 2031, per the report’s market forecasts. During the projected period of 2021–2031, the market is anticipated to see a CAGR of 4.5%.

Genital herpes is a normal sexually transmitted disease. The prevalence of health issues is increasing globally along with population density in various places. With the rise in disease prevalence, it is projected that the markets for therapies would grow dramatically.

There is a market for drugs like Acyclovir, Valacyclovir, and Famciclovir to treat STDs like genital herpes. HSV-1 and HSV-2 are among the signs and symptoms of genital herpes.

Get Sample PDF Brochure@

The increase in government spending on the healthcare sector is the main factor fueling market expansion. Many nations are putting a lot of effort into preventing infectious diseases, which benefits the market for herpes medications and increases demand from local governments and third-party payers.

Global Genital Herpes Treatment Market: Trends and Opportunities

Genital herpes therapies may have new market potential. Globally, the prevalence of herpes infection is rising, creating a market opportunity for diagnostic and treatment goods.

According to WHO estimates, 67% of the world’s population—or over 3.7 billion people—had HSV-1 infection in 2016. This suggests that the market for treating HSV disease will significantly grow over the course of the projection period. In a similar vein, 491 million people worldwide (almost 13% of those under 50) had HSV-2 infection as of 2016.

Also, the companies are aiming to provide affordable treatment options. New immunisations provide complete protection against a variety of HSV1 and HSV2 strains. Businesses are speeding up their research and development efforts to help cure and prevent genital herpes diseases. The majority of firms are focusing on the approval and introduction of generic drugs in developing countries in order to give accessible treatments for genital herpes.

Ask An Analyst@

Global Genital Herpes Treatment Market: Key Highlights from the Segmental Analysis

MEA is expected to come up as the most lucrative region in the industry. With the rise in sexually transmitted diseases in the region, the demand for genital herpes treatment is also expected to rise.

Regional analysis shows that MEA will witness a robust CAGR of 5.2% during the forecast period in the global genital herpes treatment market.  Based on the route of administration oral is the main segment, with the highest growth rate and highest market share in the global genital herpes treatment market.

Amongst various distribution channels, retail pharmacies hold the highest market size, but the segment lags behind in terms of growth rate. With the growth of online marketing and e-commerce, online pharmacies is the fastest growing segment which is expected to register a growth rate of 5.4% during the forecast period.

Global Genital Herpes Treatment Market: Top Companies

Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc., etc.

Ask for Customization@

Key Segments Covered in Genital herpes treatment Market Study

Drug Type:

  • Acyclovir
  • Valacyclovir
  • Famciclovir

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Route of Administration:

  • Oral
  • Topical
  • Injectable


  • HSV-1
  • HSV-2

Key Regions/Countries Covered:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Ex. Japan (APEJ)
  • Japan
  • Middle East & Africa

Use promo code >> FMITODAY to get flat 20% discount

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedIn| Twitter| Blogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these